Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2010

01-10-2010 | Original paper

Evaluating the impact of an educational intervention to increase CRC screening rates in the African American community: a preliminary study

Authors: Errol J. Philip, Katherine DuHamel, Lina Jandorf

Published in: Cancer Causes & Control | Issue 10/2010

Login to get access

Abstract

Background

Despite the acknowledged importance of colorectal cancer (CRC) screening and its proven prognostic benefit, African American men and women simultaneously possess the highest rates of CRC-related incidence and mortality (Swan et al. in Cancer 97(6):1528–1540, 2003) and lowest screening rates in the United States (Polite et al. in Med Clin N Am 89(4):771–793, 2005). Effective, targeted interventions that promote CRC screening for this community are therefore critical. The current study evaluated the impact of a print-based educational intervention on screening behavior and associated patient-based factors, including cancer-related knowledge, fatalism, worry, and decisional balance (pros–cons).

Methods

One hundred and eighteen individuals (mean age = 56.08, SD = 5.58) who had not undergone screening were recruited from two health clinics in New York City. Each participant received educational print materials regarding the need for screening, the process of undergoing screening, and the benefits of regular CRC screening.

Results

One in four individuals had undergone post-intervention screening at a three-month follow-up. Whereas all participants reported a decrease in cancer-related worry (p < .05), it was a decrease in fatalism (p < .05) and an increase in decisional balance (p < .05) that was associated with post-intervention screening behavior.

Discussion

These preliminary results suggest that fatalistic beliefs and an individual’s assessment of the benefits and barriers of screening may be critical in the decision to undergo CRC screening. Future interventions to increase CRC-screening rates for this community may be improved by focusing on these patient-based factors.
Literature
1.
Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97(6):1528–1540CrossRefPubMed
2.
Polite BN, Dignam JJ, Olopade OI (2005) Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin N Am 89(4):771–793CrossRefPubMed
3.
ACS (2008) The cancer experience: colon and rectum cancer
4.
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):1365–1371CrossRefPubMed
5.
Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657CrossRefPubMed
6.
Group USCSW (2007) United States Cancer Statistics: 2003 Incidence and Mortality: Department of Health and Human Services. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
7.
Wolff M, Bates T, Beck B, Young S, Ahmed SM, Maurana C (2003) Cancer prevention in underserved African American communities: barriers and effective strategies—a review of the literature. WMJ 102(5):36–40PubMed
8.
Lipkus IM, Rimer BK, Lyna PR, Pradhan AA, Conaway M, Woods-Powell CT (1996) Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J Community Health 21(6):409–427CrossRefPubMed
9.
Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R et al (2003) Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol 22(1):99–105CrossRefPubMed
10.
Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP (2007) An advance notification letter increases participation in colorectal cancer screening. J Med Screen 14(2):73–75CrossRefPubMed
11.
Fitzgibbon ML, Ferreira MR, Dolan NC, Davis TC, Rademaker AW, Wolf MS et al (2007) Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract 8(3):273–281CrossRefPubMed
12.
Myers RE, Turner B, Weinberg D, Hyslop T, Hauck WW, Brigham T et al (2004) Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 38(4):375–381CrossRefPubMed
13.
Coughlin SS, Costanza ME, Fernandez ME, Glanz K, Lee JW, Smith SA et al (2006) CDC-funded intervention research aimed at promoting colorectal cancer screening in communities. Cancer 107(5 Suppl):1196–1204CrossRefPubMed
14.
Basch CE, Wolf RL, Brouse CH, Shmukler C, Neugut A, DeCarlo LT et al (2006) Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health 96(12):2246–2253CrossRefPubMed
15.
Blumenthal DS, Fort JG, Ahmed NU, Semenya KA, Schreiber GB, Perry S et al (2005) Impact of a two-city community cancer prevention intervention on African Americans. J Natl Med Assoc 97(11):1479–1488PubMed
16.
Ford ME, Havstad S, Vernon SW, Davis SD, Kroll D, Lamerato L et al (2006) Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. Gerontologist 46(4):545–550PubMed
17.
Katz ML, Tatum C, Dickinson SL, Murray DM, Long-Foley K, Cooper MR et al (2007) Improving colorectal cancer screening by using community volunteers: results of the Carolinas cancer education and screening (CARES) project. Cancer 110(7):1602–1610CrossRefPubMed
18.
Powe BD, Ntekop E, Barron M (2004) An intervention study to increase colorectal cancer knowledge and screening among community elders. Public Health Nurs 21(5):435–442CrossRefPubMed
19.
Zubarik R, Eisen G, Zubarik J, Teal C, Benjamin S, Glaser M et al (2000) Education improves colorectal cancer screening by flexible sigmoidoscopy in an inner city population. Am J Gastroenterol 95(2):509–512CrossRefPubMed
20.
Khankari K, Eder M, Osborn CY, Makoul G, Clayman M, Skripkauskas S et al (2007) Improving colorectal cancer screening among the medically underserved: a pilot study within a federally qualified health center. J Gen Intern Med 22(10):1410–1414CrossRefPubMed
21.
Ford ME, Havstad SL, Davis SD (2004) A randomized trial of recruitment methods for older African American men in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Clin Trials 1(4):343–351CrossRefPubMed
22.
Guerra CE, Schwartz JS, Armstrong K, Brown JS, Halbert CH, Shea JA (2007) Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med 22(12):1681–1688CrossRefPubMed
23.
Kelly KM, Dickinson SL, Degraffinreid CR, Tatum CM, Paskett ED (2007) Colorectal cancer screening in 3 racial groups. American Journal of Health Behavior 31(5):502–513PubMed
24.
Ajzen I, Fishbein M (1980) Understanding attitudes and predicting social behavior: an introduction to theory and research. Prentice-Hall, Englewood Cliffs
25.
Fishbein M, Ajzen I (1975) Belief, attitude, intention, and behavior: an introduction to theory and research. Addison-Wesley, Reading
26.
Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51(3):390–395CrossRefPubMed
27.
Prochaska JO, Velicer WF (1997) The transtheoretical model of health behavior change. Am J Health Promot 12(1):38–48PubMed
28.
Rakowski W, Dube CE, Marcus BH, Prochaska JO, Velicer WF, Abrams DB (1992) Assessing elements of women’s decisions about mammography. Health Psychol 11(2):111–118CrossRefPubMed
29.
Rakowski W, Fulton JP, Feldman JP (1993) Women’s decision making about mammography: a replication of the relationship between stages of adoption and decisional balance. Health Psychol 12(3):209–214CrossRefPubMed
30.
Rakowski W, Clark MA, Pearlman DN, Ehrich B, Rimer BK, Goldstein MG et al (1997) Integrating pros and cons for mammography and Pap testing: extending the construct of decisional balance to two behaviors. Prev Med 26(5 Pt 1):664–673CrossRefPubMed
31.
Chamot E, Charvet AI, Perneger TV (2001) Predicting stages of adoption of mammography screening in a general population. Eur J Cancer 37(15):1869–1877CrossRefPubMed
32.
Costanza ME, Luckmann R, Stoddard AM, Avrunin JS, White MJ, Stark JR et al (2005) Applying a stage model of behavior change to colon cancer screening. Prev Med 41(3–4):707–719CrossRefPubMed
33.
Lauver, Henriques JB, Settersten L, Bumann MC (2003) Psychosocial variables, external barriers, and stage of mammography adoption. Health Psychol 22(6):649–653CrossRefPubMed
34.
Trauth J, Ling B, Weissfeld J et al (2003) Using the transtheoretical model to stage screening behavior for colorectal cancer. Educ Behav 30:322–336CrossRef
35.
Spencer L, Pagell F, Adams T (2005) Applying the transtheoretical model to cancer screening behavior. Am J Health Behav 29(1):36–56PubMed
36.
McAlearney AS, Reeves KW, Dickinson SL, Kelly KM, Tatum C, Katz ML et al (2008) Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer 112(2):391–398CrossRefPubMed
37.
Hay JL, Buckley TR, Ostroff JS (2005) The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 14(7):517–534CrossRefPubMed
38.
Stark JR, Bertone-Johnson ER, Costanza ME, Stoddard AM (2006) Factors associated with colorectal cancer risk perception: the role of polyps and family history. Health Educ Res 21(5):740–749CrossRefPubMed
39.
Hay JL, McCaul KD, Magnan RE (2006) Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med 42(6):401–408CrossRefPubMed
40.
Brenes GA, Paskett ED (2000) Predictors of stage of adoption for colorectal cancer screening. Prev Med 31(4):410–416CrossRefPubMed
41.
Powe BD, Finnie R (2003) Cancer fatalism: the state of the science. Cancer Nurs 26(6):454–465 quiz 66–67CrossRefPubMed
42.
Niederdeppe J, Levy AG (2007) Fatalistic beliefs about cancer prevention and three prevention behaviors. Cancer Epidemiol Biomark Prevent 16(5):998–1003CrossRef
43.
Powe BD (1996) Cancer fatalism among African-Americans: a review of the literature. Nurs Outlook 44(1):18–21CrossRefPubMed
44.
Powe BD (1994) Perceptions of cancer fatalism among African Americans: the influence of education, income, and cancer knowledge. J Natl Black Nurs Assoc 7(2):41–48
45.
Powe BD (1995) Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 18(5):385–392CrossRefPubMed
46.
Shankar S, Selvin E, Alberg AJ (2002) Perceptions of cancer in an African-American community: a focus group report. Ethn Dis 12(2):276–283PubMed
47.
Farmer D, Reddick B, D’Agostino R, Jackson SA (2007) Psychosocial correlates of mammography screening in older African American women. Oncol Nurs Forum 34(1):117–123CrossRefPubMed
48.
Spurlock WR, Cullins LS, 1 (2006) Cancer fatalism and breast cancer screening in African American women. ABNF J 17(1):38–43PubMed
49.
Remennick L (2006) The challenge of early breast cancer detection among immigrant and minority women in multicultural societies. Breast J 12(Suppl 1):S103–S110CrossRefPubMed
50.
Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum 26(3):561–571PubMed
51.
Greiner KA, Born W, Nollen N, Ahluwalia JS (2005) Knowledge and perceptions of colorectal cancer screening among urban African Americans. J Gen Intern Med 20(11):977–983CrossRefPubMed
52.
Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W et al (2002) Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 21(1):3–15CrossRefPubMed
53.
Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422CrossRefPubMed
54.
Freeman KL, Jandorf L, Thompson H, DuHamel K (2010) Colorectal cancer brochure development for African Americans. J Health Dispar Res Pract 3(3):43–56
55.
Denberg TD, Melhado TV, Coombes JM, Beaty BL, Berman K, Byers TE et al (2005) Predictors of nonadherence to screening colonoscopy. J Gen Intern Med 20(11):989–995CrossRefPubMed
56.
Bajracharya SM (2006) An assessment of the perceived barriers and strategies to promoting early detection of colorectal cancer: a practitioners’ perspective. Int Q Community Health Educ 26(1):23–44CrossRefPubMed
57.
Ward SH, Lin K, Meyer B, Bass SB, Parameswaran L, Gordon TF et al (2008) Increasing colorectal cancer screening among African Americans, linking risk perception to interventions targeting patients, communities and clinicians. J Natl Med Assoc 100(6):748–758PubMed
58.
Green PM, Kelly BA (2004) Colorectal cancer knowledge, perceptions, and behaviors in African Americans. Cancer Nurs 27(3):206–215 quiz 16–17CrossRefPubMed
Metadata
Title
Evaluating the impact of an educational intervention to increase CRC screening rates in the African American community: a preliminary study
Authors
Errol J. Philip
Katherine DuHamel
Lina Jandorf
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 10/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9597-3

Other articles of this Issue 10/2010

Cancer Causes & Control 10/2010 Go to the issue

Original paper

Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III

Original paper

Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival

Original paper

Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006

Original paper

Hormonal exposures and the risk of uveal melanoma

Original paper

Childhood cancer mortality and socioeconomic position in South Korea: a national population-based birth cohort study

Original paper

Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits